M&A Deal Summary

Akorn Acquires Advanced Vision Research

On March 5, 2011, Akorn acquired consumer products company Advanced Vision Research for 26M USD

Acquisition Highlights
  • This is Akorn’s 1st transaction in the Consumer Products sector.
  • This is Akorn’s 4th largest (disclosed) transaction.
  • This is Akorn’s 2nd transaction in the United States.
  • This is Akorn’s 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2011-03-05
Target Advanced Vision Research
Sector Consumer Products
Buyer(s) Akorn
Deal Type Add-on Acquisition
Deal Value 26M USD

Target

Advanced Vision Research

Woburn, Massachusetts, United States
Advanced Vision Research, Inc. (“AVR”), a ophthalmic company that develops and markets eye care products under the TheraTears® and MacuTrition ® brand names. These products are used for dry eyes, eyelid hygiene, contact lens comfort and eye nutrition.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Akorn

Lake Forest, Illinois, United States
Category Company
Founded 1971
Sector Life Science
Employees1,972
Revenue 1.1B USD (2016)
DESCRIPTION

Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.

DEAL STATS #
Overall 2 of 5
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 2 of 4
State (Massachusetts) 2 of 2
Country (United States) 2 of 5
Year (2011) 1 of 1
Size (of disclosed) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-09-01 Aciex Therapeutics

Boston, Massachusetts, United States

Aciex Therapeutics, Inc. is an ophthalmic pharmaceutical company centered on developing first in class products to treat ocular diseases.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-27 Hi-Tech Pharmacal

Amityville, New York, United States

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and over-the-counter (OTC) products. Hi-Tech specializes in difficult to manufacture liquid and semi-solid dosage forms and produces and markets a range of oral solutions and suspensions, as well as topical ointments and creams, nasal sprays, otics, sterile ophthalmics and sterile ointment and gels products.

Buy $640M
Mergr

Product

Company

Legal